These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a murine lymphoma model system for the characterization of natural killer:tumor cell interactions. Smithson G, Wolcott RM, Chervenak R. Cancer Res; 1992 Aug 01; 52(15):4149-56. PubMed ID: 1638530 [Abstract] [Full Text] [Related]
3. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis. Kundu N, Fulton AM. Cell Immunol; 1997 Aug 25; 180(1):55-61. PubMed ID: 9316639 [Abstract] [Full Text] [Related]
5. Antimetastatic effect of CpG DNA mediated by type I IFN. Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN. Cancer Res; 2001 Jul 15; 61(14):5523-8. PubMed ID: 11454702 [Abstract] [Full Text] [Related]
6. Perforin is a major contributor to NK cell control of tumor metastasis. Smyth MJ, Thia KY, Cretney E, Kelly JM, Snook MB, Forbes CA, Scalzo AA. J Immunol; 1999 Jun 01; 162(11):6658-62. PubMed ID: 10352283 [Abstract] [Full Text] [Related]
7. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity. Hafner M, Falk W, Echtenacher B, Männel DN. Eur Cytokine Netw; 1999 Dec 01; 10(4):541-8. PubMed ID: 10586121 [Abstract] [Full Text] [Related]
8. A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Roder JC, Lohmann-Matthes ML, Domzig W, Kiessling R, Haller O. Eur J Immunol; 1979 Apr 01; 9(4):283-8. PubMed ID: 467492 [Abstract] [Full Text] [Related]
9. Role of natural killer cells in controlling local tumor formation and metastatic manifestation of different 3LL Lewis lung carcinoma cell clones. Aboud M, Kingsmore S, Segal S. Nat Immun; 1993 Apr 01; 12(1):17-24. PubMed ID: 8431660 [Abstract] [Full Text] [Related]
10. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Coupland LA, Chong BH, Parish CR. Cancer Res; 2012 Sep 15; 72(18):4662-71. PubMed ID: 22836751 [Abstract] [Full Text] [Related]
13. Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Hanna N. Cancer Res; 1982 Apr 15; 42(4):1337-42. PubMed ID: 6277482 [Abstract] [Full Text] [Related]
15. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM. Proc Natl Acad Sci U S A; 2000 Mar 14; 97(6):2731-6. PubMed ID: 10694580 [Abstract] [Full Text] [Related]
16. Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity. Young MR, Duffie GP, Newby M. Invasion Metastasis; 1987 Mar 14; 7(2):96-108. PubMed ID: 3583624 [Abstract] [Full Text] [Related]
17. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo. Dewan MZ, Terunuma H, Takada M, Tanaka Y, Abe H, Sata T, Toi M, Yamamoto N. Breast Cancer Res Treat; 2007 Sep 14; 104(3):267-75. PubMed ID: 17066321 [Abstract] [Full Text] [Related]
18. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A. Olsson-Alheim MY, Sundbäck J, Kärre K, Sentman CL. J Immunol; 1999 Jun 15; 162(12):7010-4. PubMed ID: 10358142 [Abstract] [Full Text] [Related]
20. Triggering of murine NK cells by CD40 and CD86 (B7-2). Martín-Fontecha A, Assarsson E, Carbone E, Kärre K, Ljunggren HG. J Immunol; 1999 May 15; 162(10):5910-6. PubMed ID: 10229827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]